Nartussal (NARTEX LABORATORIOS HOMEOPATICOS SA DE CV)
Welcome to the PulseAid listing for the Nartussal drug offered from NARTEX LABORATORIOS HOMEOPATICOS SA DE CV. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | NARTEX LABORATORIOS HOMEOPATICOS SA DE CV |
NON-PROPRIETARY NAME: | Bryonia alba, Drosera rotundifolia, Ipecacuanha |
SUBSTANCE NAME: | BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2011-07-25 |
END MARKETING DATE: | 0000-00-00 |
Nartussal HUMAN OTC DRUG Details:
Item Description | Nartussal from NARTEX LABORATORIOS HOMEOPATICOS SA DE CV |
LABELER NAME: | NARTEX LABORATORIOS HOMEOPATICOS SA DE CV |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; 5; 5([hp_X]/1; [hp_X]/1; [hp_X]/1) |
START MARKETING DATE: | 2011-07-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 34666-121_f844c322-0e2c-4918-8753-357e6eaee1a8 |
PRODUCT NDC: | 34666-121 |
APPLICATION NUMBER: | |
Other BRYONIA ALBA ROOT; DROSERA ROTUNDIFOLIA; IPECAC Pharmaceutical Manufacturers / Labelers: